Neotis

Deciduous Therapeutics

This company develops small-molecule immunotherapies that activate the immune system to remove senescent cells for patients with age-related, metabolic and fibrotic diseases.

Deciduous

This company develops medicines that activate the immune system to remove senescent cells for patients with age-related metabolic and fibrotic diseases.

Rubedo.Life

This company develops small-molecule prodrugs that selectively eliminate senescent cells for patients with age-related chronic diseases and skin conditions.

Rubedo

This biopharmaceutical company develops therapeutics targeting senescent cells to treat chronic age-related diseases for patients with skin and pulmonary conditions.

Altos Labs

This biotechnology company develops cellular rejuvenation therapies to restore cell health and reverse diseases for patients with chronic illnesses and age-related disabilities.

Immunis

This biotechnology company develops stem cell-derived secretome therapies to treat age-related immune dysfunction and muscle wasting for patients with sarcopenia and metabolic diseases.

Senisca

This company develops oligonucleotide-based therapeutics that reprogramme senescent cells to treat age-related diseases and aesthetic signs of ageing for patients and pharmaceutical partners.

ImmuneAGE

This company develops a drug discovery platform for creating therapies that rejuvenate the immune system by targeting hematopoietic stem cells in the bone marrow.